Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients

Impact of pretreatment with carnitine and tadalafil on contrast-induced nephropathy in CKD patients

Objective: The present study assesses whether phosphodiesterase type 5 (PDE-5) inhibitor or carnitine exert nephroprotective effects against clinical contrast-induced nephropathy (CIN). Materials and Methods: The present study consisted of three groups of CKD patients. The first group was control gr...

Full description

Bibliographic Details
Main Authors: Zaher Armaly, Suheil Artol, Adel R. Jabbour, Amer Saffouri, Nayef Habashi, Amir Abd Elkadir, Naser Ghattas, Raymond Farah, Safa Kinaneh, William Nseir
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Renal Failure
Subjects:
radiocontrast
acute kidney injury
carnitine
phosphodiesterase 5 inhibitor
ngal
Online Access:http://dx.doi.org/10.1080/0886022X.2019.1669459

Internet

http://dx.doi.org/10.1080/0886022X.2019.1669459

Similar Items